Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20
and antiviral activity of 4’-azidocytidine analogues against hepatitis C virus replication: the discovery of 4’-azidoarabinocytidine
1219707-39-7
2013 Dec 11
C4H6O4/c1-17(20-14-13-19(2)3
Regorafenib Catalog No.:M10913-10 and antiviral activity of 4’-azidocytidineRegorafenib, also known as BAY 73 4506 ; is a n orally bioavailable small molecule with potential antiangiogenic and antineoplastic activities. Regorafenib binds to and inhibits vascular endothelial growth factor receptors (VEGFRs) 2 and 3, and Ret, Kit, PDGFR and Raf kinases, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation. Regorafenib demonstrated to increase the overall survival of patients with metastatic
US$ 35.00
US$ 78.00
US$ 60.00
US$ 124.50
US$ 85.00
US$ 112.00
US$ 147.50
US$ 169.00
US$ 160.00
US$ 42.00
US$ 150.00
US$ 40.00
US$ 150.00
US$ 17.99
US$ 108.00
US$ 42.00